Biota Holdings
- Short interest
- 1.87%
- +0.76 pp 30d
- as of 12 Nov 2012
- Reported shorts
- 3.5M
- Shares on issue
- 187.403M
Biota Holdings (BTA) Short Interest
Biota Holdings (ASX:BTA) had 1.87% of shares reported as short positions as of 12 Nov 2012, representing 3,508,047 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Biota Holdings
Biota Holdings was an Australian biotechnology company renowned for its pioneering work in antiviral drug discovery, particularly the development of zanamivir, which became the influenza drug Relenza. The company's business model focused on identifying and developing novel drug candidates, primarily in the antiviral space, and then out-licensing them to larger pharmaceutical partners for commercialization. Biota played a significant role in the global fight against influenza through its innovative research.
Company profile →Biota Holdings (ASX:BTA) has 1.87% of its shares on issue reported as short positions as of 12 Nov 2012, or about 3,508,047 shares. Over the past 30 days that figure has risen 0.76 percentage points, and over 90 days it has risen 1.52 percentage points. Its highest recorded short interest was 2.76% in October 2012. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Company details
website
Be the first to discuss BTA
Start a research thread or post the first pulse update